Voltar
Revisão Acesso aberto Revisado por pares
BIBTEX RIS

Metformin in Patients With Type 2 Diabetes and Kidney Disease

2014; American Medical Association; Volume: 312; Issue: 24 Linguagem: Inglês

10.1001/jama.2014.15298

ISSN

1538-3598

Autores

Silvio E. Inzucchi, Kasia J. Lipska, Helen Mayo, Clifford J. Bailey, Darren K. McGuire,

Tópico(s)

Pancreatic function and diabetes

Resumo

Metformin is widely viewed as the best initial pharmacological option to lower glucose concentrations in patients with type 2 diabetes mellitus. However, the drug is contraindicated in many individuals with impaired kidney function because of concerns of lactic acidosis.

Referência(s)